PAR 4.65% 20.5¢ paradigm biopharmaceuticals limited..

Paradigm Ip Patents/ Trademarks, page-21

  1. 114 Posts.
    lightbulb Created with Sketch. 34
    Hi PZ, in regards to your query on arthritis websites, I think they will have a policy of not promoting treatments that have yet to gain regulatory approval and aren't readily accessible to the public. It does nothing but frustrate sufferers to hear of potential cures that won't be on the market for years, if ever. Once confirmed by phase 3 and approved for sale, you'll see it promoted everywhere (probably by footballers).
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.